Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122407846 | 12240784 | 6 | F | 20160622 | 20160406 | 20160702 | EXP | GB-MHRA-ADR 23394648 | GB-ACCORD-039317 | ACCORD | 55.00 | YR | A | M | Y | 0.00000 | 20160702 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122407846 | 12240784 | 1 | PS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous bolus | RECEIVED AS FOLFIRI REGIMEN.??RECEIVED CYCLE 01 AND CYCLE 26. | U | UNKNOWN | 40743 | /cycle | |||||||
| 122407846 | 12240784 | 2 | SS | IRINOTECAN | IRINOTECAN | 1 | Intravenous bolus | RECEIVED AS FOLFIRI REGIMEN. | U | UNKNOWN | 79068 | /cycle | |||||||
| 122407846 | 12240784 | 3 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous drip | RECEIVED AS FOLFIRI REGIMEN.??RECEIVED CYCLE 01 AND CYCLE 26. | U | UNKNOWN | 0 | /cycle | |||||||
| 122407846 | 12240784 | 4 | SS | ZALTRAP | ZIV-AFLIBERCEPT | 1 | Unknown | ALSO RECEIVED 316 MG (SAME BATCH) CYCLICAL ON 03-FEB-2016, AND 02-MAR-2016. | U | T224534/16C2832A | 0 | 316 | MG | INFUSION | /cycle | ||||
| 122407846 | 12240784 | 5 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122407846 | 12240784 | 1 | Product used for unknown indication |
| 122407846 | 12240784 | 2 | Product used for unknown indication |
| 122407846 | 12240784 | 3 | Product used for unknown indication |
| 122407846 | 12240784 | 4 | Product used for unknown indication |
| 122407846 | 12240784 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122407846 | 12240784 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122407846 | 12240784 | Abdominal pain upper | |
| 122407846 | 12240784 | Alopecia | |
| 122407846 | 12240784 | Arthralgia | |
| 122407846 | 12240784 | Diarrhoea | |
| 122407846 | 12240784 | Dry skin | |
| 122407846 | 12240784 | Dysgeusia | |
| 122407846 | 12240784 | Dyspepsia | |
| 122407846 | 12240784 | Fatigue | |
| 122407846 | 12240784 | Gingival pain | |
| 122407846 | 12240784 | Lethargy | |
| 122407846 | 12240784 | Lip dry | |
| 122407846 | 12240784 | Neuropathy peripheral | |
| 122407846 | 12240784 | Oral herpes | |
| 122407846 | 12240784 | Oral pain | |
| 122407846 | 12240784 | Paraesthesia mucosal | |
| 122407846 | 12240784 | Paraesthesia oral | |
| 122407846 | 12240784 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122407846 | 12240784 | 4 | 20160120 | 20160120 | 0 |